Biotyx Medical
Iron-based bioabsorbable scaffolds for cardiovascular interventions
About Biotyx Medical
Biotyx Medical (Shenzhen) Co., Ltd. is a medical device company established in 2019 as a spin-off from LifeTech Scientific Corporation. The company, founded by Zhang DeYuan who also serves as CEO, focuses on the research, development, and marketing of iron-based bioabsorbable materials for medical applications, particularly for cardiovascular and peripheral vascular interventions. Biotyx Medical has developed a unique iron-based bioabsorbable material technology, positioning itself as a notable entity in this niche sector.
The company's product pipeline includes several key devices, such as the IBS™ Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System, the IBS Titan™ Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System, and the IBS Angel™ Iron Bioresorbable Scaffold System for pulmonary arteries. These products are designed to provide temporary support to blood vessels before being safely absorbed by the body, addressing conditions like coronary artery stenosis and infrapopliteal artery disease. The company's technology aims to offer the mechanical strength of traditional cobalt-chromium alloy stents while being a non-toxic, bioabsorbable solution.
Biotyx Medical has secured significant funding to advance its operations. A Series A round in November 2020 was followed by a Series B financing in September 2023, which raised over 200 million yuan (approximately $27.2 million). This funding round included investors such as GF Qianhe, Cornerstone Venture Capital, and IDG Capital. The capital is allocated towards research and development, clinical trials, commercialization efforts, and talent acquisition. The company is backed by its parent, LifeTech Scientific, and operates as a venture capital-backed, privately held entity.
Source: Dealroom company dataNews
Open roles
Biotyx Medical in the Shenzhen ecosystem
The Biotyx Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- HCHY Capital
GF Qianhe
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biotyx Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biotyx Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.